CCC Stock Overview
Cilo Cybin Holdings Limited cultivates, manufactures, and sells medical cannabis products worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Cilo Cybin Holdings Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | R4.00 |
| 52 Week High | R10.00 |
| 52 Week Low | R2.52 |
| Beta | 0 |
| 11 Month Change | -9.09% |
| 3 Month Change | -52.94% |
| 1 Year Change | n/a |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 88.24% |
Recent News & Updates
Recent updates
Shareholder Returns
| CCC | ZA Pharmaceuticals | ZA Market | |
|---|---|---|---|
| 7D | -7.0% | 2.4% | 3.8% |
| 1Y | n/a | 13.1% | 22.1% |
Return vs Industry: Insufficient data to determine how CCC performed against the ZA Pharmaceuticals industry.
Return vs Market: Insufficient data to determine how CCC performed against the ZA Market.
Price Volatility
| CCC volatility | |
|---|---|
| CCC Average Weekly Movement | 40.9% |
| Pharmaceuticals Industry Average Movement | 4.8% |
| Market Average Movement | 5.1% |
| 10% most volatile stocks in ZA Market | 10.1% |
| 10% least volatile stocks in ZA Market | 3.0% |
Stable Share Price: CCC's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine CCC's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2018 | n/a | Gabriel Theron | www.cilocybin.com |
Cilo Cybin Holdings Limited cultivates, manufactures, and sells medical cannabis products worldwide. The company offers THC and CBD oil bottles; cannabis flowers and vape products; tinctures and edibles; topicals, capsules, and devices; full and broad spectrum refined crude oil; CBD and THC distillates; and CBD, CBG, CBN, THC isolates. It also provides cannabis packaging services, storage, and exportation services to the cannabis industry.
Cilo Cybin Holdings Limited Fundamentals Summary
| CCC fundamental statistics | |
|---|---|
| Market cap | R284.07m |
| Earnings (TTM) | R455.44k |
| Revenue (TTM) | n/a |
623.7x
P/E Ratio0.0x
P/S RatioIs CCC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CCC income statement (TTM) | |
|---|---|
| Revenue | R0 |
| Cost of Revenue | R0 |
| Gross Profit | R0 |
| Other Expenses | -R455.43k |
| Earnings | R455.44k |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.0064 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 1.0% |
How did CCC perform over the long term?
See historical performance and comparison